Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed)
Status:
Completed
Trial end date:
2019-10-25
Target enrollment:
Participant gender:
Summary
This study is a randomized, open-label, fed, single dose, crossover study to investigate the
pharmacokinetic profiles and safety of high-dose CKD-385 in healthy volunteers under fed
conditions.